Light scattering optical waveguide method for detecting specific binding events

• US 5,599,668 A
• Filed: 09/22/1994
• Issued: 02/04/1997
• Est. Priority Date: 09/22/1994
• Status: Expired due to Term

• Current Assignee: Abbott Laboratories Incorporated
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Stimpson, Donald I., Gordon, Julian, Hoijer, Joanell V.
• Primary Examiner(s): Zitomer, Stephanie W.
• Assistant Examiner(s): REES, DIANE
• Application Number:
  US08/311,462
• Time in Patent Office: 866 Days
• Field of Search: 435/6, 435/5, 435/91.2, 435/7.1, 435/700, 536/22.1, 385/12
• US Class Current: 435/6.11
• CPC Class Codes: B01J 2219/00648 by the use of solid beads
• CPC Class Codes: B01J 2219/00659 Two-dimensional arrays
• CPC Class Codes: B01J 2219/00707 separated from the reactor apparatus
• CPC Class Codes: C12Q 1/6825 Nucleic acid detection involving sensors
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence
• CPC Class Codes: C12Q 2565/501 being an array of oligonucleotides
• CPC Class Codes: C12Q 2565/607 being a sensor, e.g. electrode
• CPC Class Codes: C12Q 2565/619 being a video camera
• CPC Class Codes: G01N 21/47 Scattering, i.e. diffuse reflection G01N21/25, G01N21/41 take precedence G01N21/55 takes precedence
• CPC Class Codes: G01N 21/552 Attenuated total reflection
• CPC Class Codes: G01N 21/7703 using reagent-clad optical fibres or optical waveguides using measurement of total internal reflection or attenuated total reflection G01N21/552; optical fibres or waveguides per se G02B
• CPC Class Codes: G01N 33/54373 involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings

Abstract

A waveguide binding assay method involves detecting the scattering of light directed into the waveguide, the scattering being the result of scattering labels specifically bound to the waveguide within the penetration depth of an evanescent wave. The waveguide may be transparent plastic or glass and the binding is typically by oligonucleotide hybridization or immunological capture. Light scattering labels include colloidal metals or non-metals, including gold, selenium and latex. A light absorbing member consisting of dye or concentrated particles may also be employed to enhance signal. Real-time binding and dissociation can be monitored visually or by video imaging, such as with a CCD camera and frame grabber software. Hybridization mismatches of as few as one base can be distinguished by real-time melting curves.

Claims

1. A method for detecting the presence or amount of one or more specific binding analytes in a fluid sample, the method comprising:

(a) providing a waveguide device, the waveguide device comprising (i) a transparent element having a refractive index greater than that of the fluid sample;

(ii) a light receiving edge; and

(iii) a reactive surface comprising a first specific binding member of at least one cognate binding pair immobilized at a plurality of sites on the surface of the element, other non-situs portions of the reactive surface having no specific binding member immobilized thereon;

wherein said first specific binding member, through intermediate cognate binding pairs if desired, specifically binds at least one analyte;

(b) contacting the reactive surface with a sample suspected to contain said one or more analytes and with a light scattering label attached to a specific binding member of a second cognate binding pair which, through intermediate cognate binding pairs if desired, specifically binds said one or more analytes, in the case of a sandwich assay, or the immobilized first specific binding member of said first cognate binding pair, in the case of a competitive assay;

thereby forming light scattering label complexes attached to the plurality of sites in proportion to the amount of analyte in the sample;

(c) illuminating the light receiving edge of the waveguide with light effective to create total internal reflection within the waveguide, thereby simultaneously illuminating the entire reactive surface;

(d) collecting visually detectable light scattered by said light scattering label;

(e) comparing the degree of light scattering at each situs with either (i) the degree of light scattering at a non-situs portion, or (ii) the degree of light scattering at another situs, or both, whereby light scattering at each situs correlates to the presence or amount of the analyte for which the immobilized specific binding member at that situs is specific.

2. The method of claim 1 wherein said analyte is a sequence of nucleic acid and the immobilized first specific binding member of said first cognate binding pair is an oligonucleotide complementary to said sequence or complementary to one or more cognate binding oligonucleotides, one of which is complementary to said sequence.

3. The method of claim 2 wherein said analyte nucleic acid sequence includes a hapten reporter and the specific binding member attached to said light scattering label is specific for said hapten reporter.

4. The method of claim 1 wherein said analyte is an antigen and the immobilized first specific binding member of said first cognate binding pair is an antibody.

5. The method of claim 1 wherein said element contains multiple sites each containing different concentrations of the same immobilized first specific binding member, further comprising comparing the degree of light scattering at one situs with the degree of light scattering at another situs.

6. The method of claim 5 wherein said element contains multiple sites each containing a distinct immobilized first specific binding member.

7. The method of claim 1 wherein said element contains multiple sites each containing a distinct specific binding member.

8. The method of claim 1 wherein said method further comprises a second transparent element connected to said first element to form a two-dimensional capillary channel therebetween, such that the reactive surface is formed in the channel.

9. The method of claim 1 wherein said light scattering label is a particle selected from the group consisting of colloidal gold, colloidal selenium and latex.

10. The method of claim 1 wherein light is visually collected from a plurality of sites simultaneously by an observer.

11. The method of claim 1 wherein the collection of scattered light is accomplished by an array of photodetector devices selected from the group consisting of photodiodes, charge coupled devices, phototransistors, photoresistors and photomultipliers.

12. The method of claim 11 wherein the collection of scattered light is accomplished by a CCD camera.

13. The method of claim 1 wherein said light scattering label is attached to said first specific binding member of a second cognate binding pair via an intermediate cognate binding pair selected from the group consisting of:

hapten and anti-hapten antibody;

biotin and avidin or streptavidin; and

complementary nucleic acid sequences.

14. The method of claim 1 comprising a further step, after step (e), of altering the conditions at the reactive surface of the waveguide device to initiate dissociation of the analyte from the immobilized first specific binding member, and repeating steps (c), (d) and (e) at the altered condition.

15. The method of claim 14 wherein the analyte is nucleic acid and said altering of conditions comprises increasing the stringency conditions at the reactive surface.

16. The method of claim 15 wherein stringency conditions are increased incrementally by stepwise increases in temperature.

17. The method of claim 15 wherein stringency conditions are increased incrementally by stepwise addition of a dilution agent that decreases the ionic strength of the solution.

18. The method of claim 14 wherein said altering of conditions is repeated in several increments and the repeating of steps (c), (d) and (e) is done without an intermediate washing away of dissociated analyte.

19. The method of claim 8 wherein said waveguide device is provided with a reaction surface having a coating of metasoluble protein.

20. The method of claim 1 wherein said waveguide device is provided with a reaction surface having a coating of metasoluble protein.

21. The method of claim 1 wherein said coating of metasoluble protein comprises casein.

22. The method of claim 1 wherein said contacting of step (b) further includes contacting the reactive surface with a light absorbing member effective to impart an effective O.D. of at least 15.

23. A method for visually detecting the presence or approximate amount of at least one specific binding analyte in a fluid sample, the method comprising:

(a) providing a waveguide device, the waveguide device comprising (i) a transparent element having a refractive index greater than that of the fluid sample;

(ii) a light receiving edge; and

(iii) a reactive surface comprising a first specific binding member of at least one cognate binding pair immobilized on at least one test situs on the surface of the element, other non-situs portions of the reactive surface having no specific binding member immobilized thereon;

wherein said first specific binding member, through intermediate cognate binding pairs if desired, specifically binds said analyte;

(b) contacting the reactive surface with the sample suspected to contain said analyte and with a light scattering label attached to a first specific binding member of a second cognate binding pair which, through intermediate cognate binding pairs if desired, specifically binds said analyte, in the case of a sandwich assay, or the immobilized first specific binding member, in the case of a competitive assay;

thereby forming light scattering label complexes attached to the situs in proportion to the amount of the analyte in the sample;

(c) illuminating the light receiving edge of the waveguide with light effective to create total internal reflection within the waveguide, thereby illuminating the reactive surface;

(d) visually examining the reactive surface for light scattering and comparing the degree of light scattering at the test situs with either (i) the degree of light scattering at a non-situs portion, or (ii) the degree of light scattering at another situs, or both, whereby scattering at the situs correlates to the presence or amount of said analyte.

24. The method of claim 23 wherein said analyte is a sequence of nucleic acid and the immobilized first specific binding member of said first cognate binding pair is an oligonucleotide complementary to said sequence or complementary to one or more cognate binding oligonucleotides, one of which is complementary to said sequence.

25. The method of claim 23 wherein said analyte nucleic acid sequence includes a hapten reporter and the specific binding member attached to said light scattering label is specific for said hapten reporter.

26. The method of claim 23 wherein said analyte is an antigen and the immobilized first specific binding member of said first cognate binding pair is an antibody.

27. The method of claim 23 wherein said element contains a plurality of test sites, each containing immobilized specific binding member.

28. The method of claim 27 wherein said plurality of test sites each contain varying concentrations of the same immobilized first specific binding member.

29. The method of claim 27 wherein said plurality of test sites each contain a distinct immobilized first specific binding member.

30. The method of claim 23 wherein said method further comprises a second transparent element connected to said first element to form a two-dimensional capillary channel therebetween, such that the reactive surface is formed in the channel.

31. The method of claim 23 wherein said light scattering label is a particle selected from the group consisting of colloidal gold, colloidal selenium and latex.

32. The method of claim 23 comprising a further step, after step (d), of altering the conditions at the reactive surface of the waveguide device to initiate dissociation of the analyte from the immobilized first specific binding member, and repeating steps (c) and (d) at the altered condition.

33. The method of claim 23 wherein said waveguide device is provided with a reaction surface having a coating of metasoluble protein.

34. The method of claim 33 wherein said coating of metasoluble protein comprises casein.

35. The method of claim 23 wherein said contacting of step (b) further includes contacting the reactive surface with a light absorbing member sufficient to impart an effective O.D. of at least 15.

36. The method of claim 35 wherein the effective O.D. is at least 100.

37. A method for detecting the presence or amount of at least one specific binding analyte in a fluid sample, the method comprising:

(a) providing a waveguide device, the waveguide device comprising (i) a transparent element having a refractive index greater than that of the fluid sample;

(ii) a light receiving edge; and

(iii) a reactive surface comprising a first specific binding member of at least one cognate binding pair immobilized at a situs on the surface of the element, other non-situs portions of the reactive surface having no specific binding member immobilized thereon;

wherein said first specific binding member, through intermediate cognate binding pairs if desired, specifically binds said analyte;

(b) contacting the reactive surface with the sample suspected to contain said analyte and with a light scattering label attached to a first specific binding member of a second cognate binding pair which, through intermediate cognate binding pairs if desired, specifically binds said analyte, in the case of a sandwich assay, or the immobilized first specific binding member, in the case of a competitive assay;

thereby forming light scattering label complexes attached to said situs in proportion to the amount of analyte in the sample;

(c) illuminating the light receiving edge of the waveguide with light effective to create total internal reflection within the waveguide, thereby simultaneously illuminating the entire reactive surface;

(d) collecting visually detectable light scattered by said light scattering label at a first time, t₁, using a photodetector device;

(e) repeating steps (c) and (d) at least once to collect scattered light, if any, from said situs and non-situs portions at a second time, t₂ ; and

(f) comparing the degree of light scattering at said situs at time t₁ with the degree of light scattering at said situs at time t₂, whereby the light scattering at the situs correlates to the presence or amount of the specific analyte, and the difference over time in scattering of light provides kinetic information indicative of the amount of analyte present at said situs.

38. The method of claim 37 wherein said analyte is a sequence of nucleic acid and the immobilized first specific binding member of said first cognate binding pair is an oligonucleotide complementary to said sequence or complementary to one or more cognate binding oligonucleotides, one of which is complementary to said sequence.

39. The method of claim 37 wherein said analyte nucleic acid sequence includes a hapten reporter and the specific binding member attached to said light scattering label is specific for said hapten reporter.

40. The method of claim 37 wherein said analyte is an antigen and the immobilized first specific binding member of said first cognate binding pair is an antibody.

41. The method of claim 37 wherein said element contains a plurality of test sites, each situs containing immobilized specific binding member which is the same or different from immobilized specific binding member at another situs.

42. The method of claim 37 wherein said method further comprises a second transparent element connected to said first element to form a two-dimensional capillary channel therebetween, such that the reactive surface is formed in the channel.

43. The method of claim 37 wherein said light scattering label is a particle selected from the group consisting of colloidal gold, colloidal selenium and latex.

44. The method of claim 37 wherein said step of collecting scattered light is performed using a CCD camera.

45. The method of claim 37 comprising a further step, after step (f), of altering the conditions at the reactive surface of the waveguide device to initiate dissociation of the analyte from the immobilized first specific binding member, and repeating steps (c), (d) and (f) at the altered condition.

46. The method of claim 37 wherein said waveguide device is provided with a reaction surface having a coating of metasoluble protein.

47. The method of claim 46 wherein said coating of metasoluble protein comprises casein.

48. The method of claim 37 wherein said contacting of step (b) further includes contacting the reactive surface with a light absorbing member sufficient to impart an effective O.D. of at least 15.

49. A method for determining the nucleotide sequence of segment of unknown nucleic acid or for distinguishing two closely related nucleotide sequences, the method comprising:

(a) providing a waveguide device, the waveguide device comprising (i) a transparent element having a refractive index greater than that of the fluid sample;

(ii) a light receiving edge; and

(iii) a reactive surface comprising a plurality of sites having oligonucleotide immobilized thereon, said sites defining an array of oligonucleotides having different sequences for hybridizing with the unknown nucleic acid, other non-situs portions of the surface of said element having no oligonucleotides immobilized thereon;

(b) contacting the reactive surface under hybridizing conditions with said unknown nucleic acid wherein said unknown nucleic acid, either directly or through intermediate cognate binding pairs if desired, is labeled with a light scattering label;

thereby forming light scattering label complexes attached at those sites of the reactive surface having an oligonucleotide, complementary to the sequence of the unknown nucleic acid, immobilized thereon;

(c) illuminating the light receiving edge of the waveguide with light effective to create total internal reflection within the waveguide, thereby simultaneously illuminating the entire reactive surface;

(d) collecting visually detectable light scattered by said light scattering label;

(e) comparing the degree of light scattering at each situs with either (i) the degree of light scattering at a non-situs portion;

or (ii) the degree of light scattering at another situs; and

(f) further comprising incrementally increasing the stringency conditions at the reactive surface of the waveguide device to initiate dissociation of bound nucleic acid from the sites and repeating steps (d) and (e) at each increment;

whereby single base pair differences between the oligonucleotides and the unknown nucleic acid can be distinguished from perfect matches by differences in dissociation properties.

50. The method of claim 49 wherein said analyte nucleic acid sequence includes a hapten reporter and the specific binding member attached to said light scattering label is specific for said hapten reporter.

51. The method of claim 49 wherein said method further comprises a second transparent element connected to said first element to form a two-dimensional capillary channel therebetween, such that the reactive surface is formed in the channel.

52. The method of claim 49 wherein said light scattering label is a particle selected from the group consisting of colloidal gold, colloidal selenium and latex.

53. The method of claim 49 wherein the substantially simultaneous collection of scattered light from a plurality of sites is accomplished visually by eye and brain of an observer.

54. The method of claim 49 wherein the substantially simultaneous collection of scattered light is accomplished by an array of photodetector devices selected from the group consisting of photodiodes, charge coupled devices, phototransistors, photoresistors and photomultipliers.

55. The method of claim 54 wherein the substantially simultaneous collection of scattered light is accomplished by a CCD camera.

56. The method of claim 49 wherein said light scattering label is attached to said first specific binding member of a second cognate binding pair via an intermediate cognate binding pair selected from the group consisting of:

hapten and anti-hapten antibody;

biotin and avidin or streptavidin; and

complementary nucleic acid sequences.

57. The method of claim 49 wherein stringency conditions are increased incrementally by stepwise increases in temperature.

58. The method of claim 49 wherein stringency conditions are increased incrementally by stepwise addition of a dilution agent that decreases the ionic strength of the solution.

59. The method of claim 49 wherein the repeating of steps (d) and (e) is done without an intermediate washing away of dissociated unknown nucleic acid.

60. The method of claim 49 wherein said waveguide device is provided with a reaction surface having a coating of metasoluble protein.

61. The method of claim 60 wherein said coating of metasoluble protein comprises casein.

62. The method of claim 49 wherein said contacting of step (b) further includes contacting the reactive surface with a light absorbing member effective to impart an effective O.D. of at least 15.

63. A method for detecting the presence or mount of a specific binding analyte in a fluid sample, the method comprising:

(a) providing a TIR device, the device comprising (i) a transparent TIR element having a refractive index greater than that of the fluid sample;

(ii) a light receiving edge; and

(iii) a reactive surface comprising a first specific binding member of at least one cognate binding pair immobilized on at least one situs on the surface of the element, other non-situs portions of the reactive surface having no specific binding member immobilized thereon;

wherein said first specific binding member, through intermediate cognate binding pairs if desired, specifically binds said analyte;

(b) contacting the reactive surface with (i) the sample suspected to contain said analyte;

(ii) a light scattering label attached to a first specific binding member of a second cognate binding pair which, through intermediate cognate binding pairs if desired, specifically binds said analyte, in the case of a sandwich assay, or the immobilized first specific binding member, in the case of a competitive assay, thereby forming light scattering label complexes attached to said situs in proportion to the amount of analyte in the sample; and

(iii) a solution of a light absorbing member sufficient to impart an effective O.D. of at least 15;

(c) illuminating the light receiving edge of the TIR element with light effective to create total internal reflection within the element, thereby illuminating the reactive surface;

(d) detecting visually detectable light scattered by said light scattering label and comparing the degree of light scattering at the situs with the degree of light scattering at a non-situs portion, whereby background scattering is minimized by absorbance by the light absorbing material.

64. The method of claim 63 wherein said analyte is a sequence of nucleic acid and the immobilized first specific binding member of said first cognate binding pair is an oligonucleotide complementary to said sequence or complementary to one or more cognate binding oligonucleotides, one of which is complementary to said sequence.

65. The method of claim 63 wherein said analyte nucleic acid sequence includes a hapten reporter and the specific binding member attached to said light scattering label is specific for said hapten reporter.

66. The method of claim 63 wherein said analyte is an antigen and the immobilized first specific binding member of said first cognate binding pair is an antibody.

67. The method of claim 63 wherein said element contains a plurality of test sites, each situs containing immobilized specific binding member which is the same or different from immobilized specific binding member at another situs.

68. The method of claim 63 wherein said TIR element is two-dimensional and said TIR device further comprises a second two-dimensional transparent element connected to said TIR element to form a two-dimensional capillary channel therebetween, such that the reactive surface is formed in the channel.

69. The method of claim 63 wherein said light scattering label is a particle selected from the group consisting of colloidal gold, colloidal selenium and latex.

70. The method of claim 63 wherein detecting scattered light is accomplished visually by eye and brain of an observer.

71. The method of claim 63 wherein detecting scattered light is accomplished by an array of photodetector devices selected from the group consisting of photodiodes, charge coupled devices, phototransistors, photoresistors and photomultipliers.

72. The method of claim 63 comprising a further step, after step (d), of altering the conditions at the reactive surface of the waveguide device to initiate dissociation of the analyte from the immobilized first specific binding member, and repeating steps (c) and (d) at the altered condition.

73. The method of claim 72 wherein the analyte is a nucleic acid and the step of altering conditions comprises increasing the stringency by increased heat or by decreased ionic strength.

74. The method of claim 63 wherein said waveguide device is provided with a reaction surface having a coating of metasoluble protein.

75. The method of claim 74 wherein said coating of metasoluble protein comprises casein.

76. The method of claim 63 wherein the light absorbing material is the light scattering label in a concentration sufficient to impart an effective O.D. of 15.

77. The method of claim 76 wherein the light absorbing material is selected from the group consisting of colloidal metals, colloidal non-metals, and latex particles.

78. The method of claim 63 wherein the light absorbing material is a dye selected from the group consisting of azo dyes, diazo dyes, triazine dyes, food colorings and biological stains.

79. The method of claim 63 wherein the effective O.D. is at least 100.

80. The method of claim 79 wherein the effective O.D. is at least 300.